Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Provision for income tax	$ 13	$ 5	$ 28	$ 10
Effective income tax rate	0.20%	0.10%	0.20%	0.10%

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.